β-arrestin 2负调控TLR9信号抑制肺腺癌的增殖与转移

基本信息
批准号:81372299
项目类别:面上项目
资助金额:70.00
负责人:李钦传
学科分类:
依托单位:同济大学
批准年份:2013
结题年份:2017
起止时间:2014-01-01 - 2017-12-31
项目状态: 已结题
项目参与者:汪进益,李砚东,洪暄,吴晨明
关键词:
肺肿瘤TLR9βarrestin转移2C05_气管支气管调控
结项摘要

Lung adenocarcinoma is the most common type of lung cancer. It has a poor prognosis and high mortality rate in patients in late stage and/or with recurrent conditions. However, the mechanisms by which genes play a critical role in lung cancer metastasis and recurrence remain elusive. Recently, it has been demonstrated by us and others that immune functions contribute to cancer metastasis and the recurrence process. Toll-like receptors (TLRs) play a fundamental role in modulation of human immune function and inflammatory responses. Importantly, our recent results have shown that TLR9 participates in lung cancer metastasis. β-arrestin 2 (β-Arr2) regulates TLR-mediated signaling pathways; however, the role of β-Arr2 and TLR9 in lung adenocarcinoma metastasis and recurrence are not known yet. Our proposal focuses on the mechanisms by which β-Arr2 and TLR9 contribute to lung adenocarcinoma metastasis and recurrence. We will define the effects and modulatory mechanisms of overexpression of β-Arr2 and/or inhibition of TLR9 and chemotherapy on lung adenocarcinoma metastasis and recurrence. We will utilize overexpression of β-Arr2 in lung adenocarcinoma cells to define the role of β-Arr2 and TLR9-mediated signaling pathways in lung adenocarcinoma invasiveness. We will use lung adenocarcinoma in mice and human lung adenocarcinoma samples to investigate the effects ofβ-Arr2 and TLR9-mediated signaling pathways on lung adenocarcinoma metastasis and recurrence during chemotherapy. The successful completion of this proposal will identify new approaches for the treatment of patients with lung adenocarcinoma.

Toll样受体(TLR)9和β-arrestin(β-Arr)2均与肿瘤转移有关,前期研究发现两者共用PI3K/Akt分别抑制和促进肺癌细胞凋亡,最近发现β-Arr2负调控免疫细胞TLRs信号级联, 推测β-Arr2与TLR9的分子交谈将影响肺腺癌的进展。为此,本研究拟围绕肺腺癌细胞和临床标本,借助基因转染、MTT、FACS、EMSA、WB、激光共聚焦、免疫共沉淀和移植瘤模型等技术手段,①观察β-Arr2对TLR9介导的细胞凋亡转移的影响;②判断β-Arr2、TLR9、TRAF6及Akt 的表达及共定位关系;③ 测定TLR9、MyD88、TRAF6及Akt/GSK-3β的表达及其磷酸化水平;④检测PI3K、IRAK/IKK活性与NF-κB结合活性;⑤分析TLR9及其下游分子、β-Arr2表达状态与腺癌转移和化疗抵抗的关系。以阐明β-Arr2对TLR9介导的肺腺癌增殖和转移的调控作用与机制

项目摘要

Toll样受体(TLR)9和β-arrestin(β-Arr)2均与肿瘤转移有关,前期研究发现两者共用PI3K/Akt分别抑制和促进肺癌细胞凋亡,最近发现β-Arr2负调控免疫细胞TLRs信号级联, 推测β-Arr2与TLR9的分子交谈将影响肺腺癌的进展。为此,本研究拟围绕肺腺癌细胞和临床标本,借助基因转染、MTT、FACS、EMSA、WB、激光共聚焦、免疫共沉淀和移植瘤模型等技术手段,①观察β-Arr2对TLR9介导的细胞凋亡转移的影响;②判断β-Arr2、TLR9、TRAF6及Akt 的表达及共定位关系;③ 测定TLR9、MyD88、TRAF6及Akt/GSK-3β的表达及其磷酸化水平;④检测PI3K、IRAK/IKK活性与NF-κB结合活性;⑤分析TLR9及其下游分子、β-Arr2表达状态与腺癌转移和化疗抵抗的关系。以阐明β-Arr2对TLR9介导的肺腺癌增殖和转移的调控作用与机制。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
2

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021
3

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

DOI:10.1080/15476286.2017.1377868.
发表时间:2017
4

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

DOI:10.2147/DDDT.S163951
发表时间:2018
5

IRE1-RACK1 axis orchestrates ER stress preconditioning-elicited cytoprotection from ischemia/reperfusion injury in liver

IRE1-RACK1 axis orchestrates ER stress preconditioning-elicited cytoprotection from ischemia/reperfusion injury in liver

DOI:
发表时间:2016

相似国自然基金

1

β-arrestin2负调控MyD88与乳腺癌化疗耐药机制的研究

批准号:81102019
批准年份:2011
负责人:赵苗青
学科分类:H1821
资助金额:22.00
项目类别:青年科学基金项目
2

RIG-G基因抑制肺腺癌细胞增殖的作用与机制

批准号:81272603
批准年份:2012
负责人:李冬
学科分类:H1802
资助金额:60.00
项目类别:面上项目
3

β-arrestin 2对TLR9介导的心肌缺血再灌注损伤的调控机理

批准号:81570454
批准年份:2015
负责人:尹德领
学科分类:H0219
资助金额:57.00
项目类别:面上项目
4

Fbxw7通过负调控SOX10抑制肿瘤增殖及转移的机制研究

批准号:81560452
批准年份:2015
负责人:吕小斌
学科分类:H1803
资助金额:40.00
项目类别:地区科学基金项目